Clinical trial
OP5-005 Using Omnipod 5 in Adults With Type 2
NCT05815342
Study timeline
Study start (actual)2023-04-11Date precision: day
Registry last updated2025-09-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type2 Diabetesunresolved
Interventions
Sponsors & collaborators
Insulet Corporationlead sponsor
Jaeb Center for Health Researchcollaborator
Mapped research locations
BostonMassachusetts, United States1Los AngelesCalifornia, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1ColumbusOhio, United States1MinneapolisMinnesota, United States1JacksonvilleFlorida, United States1AuroraColorado, United States1DetroitMichigan, United States1AustinTexas, United States1Chapel HillNorth Carolina, United States1The BronxNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05815342 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.